Private demand for cholera vaccines in Beira, Mozambique

Vaccine

Volumn 25, Issue 14, 2007, Pages 2599-2609

  Lucas, Marcelino E S ^a   Jeuland, Marc ^b   Deen, Jacqueline ^c   Lazaro, Nivalda ^d   MacMahon, Melissa ^b   Nyamete, Andrew ^c   Barreto, Avertino ^e   von Seidlein, Lorenz ^c   Cumbane, Arnaldo ^d   Songane, Francisco F ^f   Whittington, Dale ^b  

^a MINISTRY OF SCIENCE AND TECHNOLOGY   (Mozambique)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c International Vaccine Institute   (South Korea)

^d Center for Environmental Hygiene and Medical Examination   (Mozambique)

^e MINISTRY OF HEALTH   (Mozambique)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cholera; Contingent valuation method; Vaccine demand; Willingness to pay

Indexed keywords

CHOLERA VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CHOLERA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; ENDEMIC DISEASE; FEMALE; HEALTH CARE COST; HEALTH CARE NEED; HEALTH SURVEY; HOUSEHOLD; HUMAN; INTERVIEW; MALE; MOZAMBIQUE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZATION; SELF CARE; VACCINATION;

CHOLERA VACCINES; COSTS AND COST ANALYSIS; HUMANS; MOZAMBIQUE; VACCINATION;

EID: 33947154745     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.12.027     Document Type: Article

References (16)

1. WHO. Cholera, 2004. Wkly Epidemiol Rec 80 31 (2005) 261-268
2. Ansaruzzaman M., Lucas M., Deen J.L., Bhuiyan N.A., Wang X.-Y., Safa A., et al. Pandemic Serovars (O3:K6 and O4:K68) of Vibrio parahaemolyticus associated with diarrhea in Mozambique: spread of the pandemic into the African continent. J Clin Microbiol 43 6 (2005) 2559-2562
3. Lucas M.E.S., Deen J.L., Von Seidlein L., Wang X.-Y., Ampuero J., Puri M., et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352 8 (2005) 757-767
4. Sanchez J.L., and Vasquez B. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military. Lancet 344 8932 (1994) 1273-1275
5. Clemens J., Sack D., Harris J., Chakraborty J., Khan M., Stanton B., et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 2 8499 (1986) 124-127
6. Clemens J.D., and Sack D.A. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335 8684 (1990) 270-272
7. Hanemann W.M. Valuing the environment through contingent valuation. J Econ Perspect 8 4 (1994) 19-43
8. Carson R.T. Contingent valuation: a user's guide. Environ Sci Technol 34 8 (2000) 1413-1418
9. Cropper M.L., Haile M., Lampietti J., Poulos C., and Whittington D. The demand for a malaria vaccine: evidence from Ethiopia. J Dev Econ 75 1 (2004) 303-318
10. Whittington D., Matsui-Santana O., Freiberger J.J., Van Houtven G., and Pattanayak S. Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico. Vaccine 20 19/20 (2002) 2585-2591
11. Canh D.G., Whittington D., Thoa L.T.K., Utomo N., Hoa N.T., and Poulos C. Household demand for typhoid fever vaccines in Hue City, Vietnam: implications for immunization programs. Health Policy Plann 21 3 (2006) 241-255
12. Cook J., Whittington D., Canh D.G., Johnson F.R., and Nyamete A. Reliability of stated preferences for cholera and typhoid vaccines with time to think in Hue, Vietnam. Econ Inq 45 1 (2007) 100-114
13. INE. Second National Census. Maputo, Mozambique, 1998.
14. Whittington D. Improving the performance of contingent valuation studies in developing countries. Environ Resour Econ 22 1-2 (2002) 323-367
15. Blumenschein K., Johannesson M., Yokoyama K.K., and Freeman P.R. Hypothetical versus real willingness to pay in the health care sector: results from a field experiment. J Health Econ 20 3 (2001) 441-457
16. Cameron A.C., and Trivedi P.K. Econometric models based on count data: comparisons and applications of some estimators and tests. J Appl Econometr 1 1 (1986) 29-53